Giacalone V F
Diabetic Foot Care Center, Westwood, NJ 07675, USA.
J Foot Ankle Surg. 1997 Jul-Aug;36(4):264-7; discussion 328. doi: 10.1016/s1067-2516(97)80070-1.
The aim of this study was to describe the safety and effectiveness associated with phenol matricectomy in patients with diabetes. To date, the medical literature is devoid of information regarding the use of chemical toenail matricectomies performed on patients with diabetes. Sixty-six consecutive patients with diabetes and ingrown toenails were evaluated. The procedure was performed on 57 of these patients. The results demonstrate a 5% regrowth rate, no significant complications, and limited risk in this patient population.
本研究的目的是描述糖尿病患者行苯酚甲床切除术的安全性和有效性。迄今为止,医学文献中缺乏关于对糖尿病患者进行化学性趾甲甲床切除术的相关信息。对66例连续性糖尿病伴嵌甲患者进行了评估。其中57例患者接受了该手术。结果显示,该患者群体的复发率为5%,无显著并发症,风险有限。